World Health Organization. Breast cancer [Internet]. Geneva; 2023. Available from: Doi: https://www.who.int/news-room/fact-sheets/detail/breast-cancer

Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77(9):1745–70. https://doi.org/10.1007/s00018-019-03351-7.

Article  CAS  PubMed  Google Scholar 

Testa U, Castelli G, Pelosi E. Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments. Med Sci. 2020;8(1):18. https://doi.org/10.3390/medsci8010018.

Article  CAS  Google Scholar 

Cain EH, Saha A, Harowicz MR, Marks JR, Marcom PK, Mazurowski MA. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set. Breast Cancer Res Treat. 2019;173(2):455–63.

Article  CAS  PubMed  Google Scholar 

Wang X, Qian T, Bao S, Zhao H, Chen H, Xing Z, et al. Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer. Mol Oncol. 2021;15(9):2466–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alwan NAS. Breast cancer among Iraqi women: preliminary findings from a regional comparative breast cancer research project. J Glob Oncol. 2016;2(5):255–8.

Article  PubMed  PubMed Central  Google Scholar 

Turner KM, Yeo SK, Holm TM, Shaughnessy E, Guan JL. Heterogeneity within molecular subtypes of breast cancer. Am J Physiol Cell Physiol. 2021;321(2):C343–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raheem AR, Abdul-Rasheed OF, Khattab OS, Abdulhameed AZ, Abid HA. Diagnostic and differential efficacy of cyclin D1 and CA15–3 in breast cancer and benign breast tumors. J Angiother. 2023;7(1):7335. https://doi.org/10.25163/angiotherapy.717335.

Article  Google Scholar 

Wallwiener M, Simoes E, Sokolov A, Brucker S, Fasching P, Graf J. Health-related quality of life in metastatic and adjuvant breast cancer patients. Geburtshilfe Frauenheilkd. 2016;76(10):1065–73. https://doi.org/10.1055/s-0042-113188.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Centers for Disease Control and Prevention (CDC). An update on cancer deaths in the United States. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, Division of Cancer Prevention and Control; 2022.

Brandt J, Garne J, Tengrup I, Manjer J. Age at diagnosis in relation to survival following breast cancer: a cohort study. World J Surg Oncol. 2015;13(1):33.

Article  PubMed  PubMed Central  Google Scholar 

Molina R, Barak V, Van Dalen A, Duffy MJ, Einarsson R, Gion M, et al. Tumor markers in breast cancer - European group on tumor markers recommendations. Tumor Biol. 2005;26(6):281–93.

Article  Google Scholar 

Ranganathan K, Sivasankar V. MicroRNAs— Biology and clinical applications. J Oral Maxillofac Pathol. 2014;18(2):229.

Article  PubMed  PubMed Central  Google Scholar 

Otmani K, Lewalle P. Tumor suppressor miRNA in cancer cells and the tumor microenvironment: Mechanism of deregulation and clinical implications. Front Oncol. 2021;11:8765. https://doi.org/10.3389/fonc.2021.708765.

Article  CAS  Google Scholar 

Nik Mohamed Kamal NNSB, Shahidan WNS. Non-exosomal and exosomal circulatory microRNAs: which are more valid as biomarkers? Front Pharmacol. 2020;10:1500. https://doi.org/10.3389/fphar.2019.01500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eichelser C, Stückrath I, Müller V, Milde-Langosch K, Wikman H, Pantel K, et al. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget. 2014;5(20):9650.

Article  PubMed  PubMed Central  Google Scholar 

Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69(Suppl. 3):4–10.

Article  CAS  PubMed  Google Scholar 

Madu CO, Wang S, Madu CO, Lu Y. Angiogenesis in breast cancer progression, diagnosis, and treatment. J Cancer. 2020;11(15):4474–94. https://doi.org/10.7150/jca.44313.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, Gómez-Valles FO, Ramírez-Valdespino CA. Subtypes of breast cancer [Internet]. Breast Cancer. 2022. https://doi.org/10.36255/exon-publications-breast-cancer-subtypes.

Article  Google Scholar 

Sharma JD, Khanna S, Ramchandani S, Kakoti LM, Baruah A, Mamidala V. Prevalence of molecular subtypes of breast carcinoma and its comparison between two different age groups: A retrospective study from a tertiary care center of northeast India. South Asian J Cancer. 2021;10(04):220–4. https://doi.org/10.1055/s-0041-1731905.

Article  PubMed  PubMed Central  Google Scholar 

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9. https://doi.org/10.3322/caac.21388.

Article  PubMed  Google Scholar 

Zha X, Wang F, Wang Y, He S, Jing Y, Wu X, et al. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res. 2011;71(1):13–8. https://doi.org/10.1158/0008-5472.CAN-10-1668.

Article  CAS  PubMed  Google Scholar 

Magaki S, Hojat SA, Wei B, So A, Yong WH, Yong WH et al. Biobanking methods and protocols an introduction to the performance of immunohistochemistry. Springer, New York; 2019. p. 289–298.

Book  Google Scholar 

Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, et al. Estrogen and progesterone receptor testing in breast cancer: asco/cap guideline update. J Clin Oncol. 2020;38(12):1346–66. https://doi.org/10.1200/JCO.19.02309

Article  PubMed  Google Scholar 

Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer Targets Ther. 2019;11:151–64.

Article  Google Scholar 

Wolff AC, Hammond MEH, Hicks DG, Dowsett M, McShane LM, Alliso KH. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: american society of clinical oncology/college of american pathologists clinical practice guideline update. J Clin Oncol. 2013;31:31. https://doi.org/10.1200/JCO.2013.50.9984

Article  Google Scholar 

Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast. 2022;66:15–23.

Article  PubMed  PubMed Central  Google Scholar 

Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020. Cancer Commun. 2021;41(11):1183–94. https://doi.org/10.1002/cac2.12207.

Article  Google Scholar 

Dorjgochoo T, Deming SL, Gao Y-T, Lu W, Zheng Y, Ruan Z, et al. History of benign breast disease and risk of breast cancer among women in China: a case–control study. Cancer Causes Control. 2008;19(8):819–28.

Article  PubMed  PubMed Central  Google Scholar 

Liu L, Hao X, Song Z, Zhi X, Zhang S, Zhang J. Correlation between family history and characteristics of breast cancer. Sci Rep. 2021;11(1):6360. https://doi.org/10.1038/s41598-021-85899-8.

Article  CAS  PubMed  Google Scholar 

Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K. Breast cancer surveillance consortium. Population-attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol. 2017;3(9):1228–36. https://doi.org/10.1001/jamaoncol.2016.6326.

Article  Google Scholar 

Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, et al. The role of microenvironment in tumor angiogenesis. J Exp Clin Cancer Res. 2020;39(1):204.

Article  PubMed  PubMed Central  Google Scholar 

Swellam M, El Magdoub HM, Hassan NM, Hefny MM, Sobeih ME. Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters. Clin Biochem. 2018;56:47–54.